CoverageForm 410-K10-Q8-K13D13G13F

SBUX Starbucks Corp - 8-K

Filed Mar 30, 2026. See issuer overview · financials · original on SEC.gov ↗
Accession
0000829224-26-000058
5.07

Item 5.07 - Submission of Matters to a Vote of Security Holders

694 words

Item 5.07 Submission of Matters to a Vote of Security Holders.

On March 25, 2026, Starbucks Corporation (the “Company”) held its 2026 Annual Meeting of Shareholders (the “Annual Meeting”). The matters submitted to a vote at the Annual Meeting and the voting results of such matters are as follows:

Proposal 1 - Election of Directors

The Company’s shareholders elected each of the eleven directors nominated by the Company’s Board of Directors to serve until the 2027 Annual Meeting of Shareholders or until their successors are duly elected and qualified. The following is a breakdown of the voting results:

Name of Nominee

For

Against

Withheld

Broker Non-Votes

Ritch Allison

846,955,724

28,832,837

1,081,482

127,972,619

Andy Campion

764,749,951

110,976,652

1,143,440

127,972,619

Beth Ford

808,145,942

66,979,908

1,744,193

127,972,619

Jørgen Vig Knudstorp

828,586,462

46,185,327

2,098,254

127,972,619

Marissa Mayer

867,967,230

7,925,365

977,448

127,972,619

Neal Mohan

865,313,815

10,401,952

1,154,276

127,972,619

Dambisa Moyo

864,744,438

11,015,863

1,109,742

127,972,619

Brian Niccol

830,353,482

43,094,658

3,421,903

127,972,619

Daniel Servitje

841,710,171

33,992,034

1,167,838

127,972,619

Mike Sievert

863,809,451

11,894,524

1,166,068

127,972,619

Wei Zhang

855,876,306

19,854,913

1,138,824

127,972,619

Proposal 2 - Advisory Resolution on Executive Compensation

At the Annual Meeting, the shareholders approved, on a nonbinding, advisory basis, the compensation paid to the Company’s named executive officers. The following is a breakdown of the voting results:

For

Against

Abstain

Broker Non-Votes

774,932,476

99,362,557

2,575,010

127,972,619

Proposal 3 - Ratification of the Selection of Deloitte & Touche LLP as the Company’s Independent Registered Public Accounting Firm for Fiscal Year 2026

At the Annual Meeting, the shareholders approved the ratification of the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending September 27, 2026. The following is a breakdown of the voting results:

For

Against

Abstain

Broker Non-Votes

965,325,253

38,304,225

1,213,184

——

Proposal 4 - Shareholder Proposal Requesting Supermajority Shareholder Voting Requirements be Replaced with Majority Voting Requirements

At the Annual Meeting, the shareholders approved a shareholder proposal requesting supermajority shareholder voting requirements be replaced with majority voting requirements. The following is a breakdown of the voting results:

For

Against

Abstain

Broker Non-Votes

823,985,324

17,573,051

30,866,556

132,323,108

Proposal 5 - Shareholder Proposal Requesting Adoption of an Independent Board Chair Policy

At the Annual Meeting, the shareholders did not approve a shareholder proposal requesting adoption of an independent board chair policy. The following is a breakdown of the voting results:

For

Against

Abstain

Broker Non-Votes

107,793,749

763,797,502

5,278,792

127,972,619

Proposal 6 - Shareholder Proposal Requesting a Report on the Company’s Apparent Exclusion of Detransitioning in its Healthcare Coverage

At the Annual Meeting, the shareholders did not approve a shareholder proposal requesting a report on the Company’s apparent exclusion of detransitioning in its healthcare coverage. The following is a breakdown of the voting results:

For

Against

Abstain

Broker Non-Votes

8,169,593

861,170,343

7,530,107

127,972,619

Proposal 7 - Shareholder Proposal Requesting a Report on Median Compensation and Benefits Gaps as They Address Reproductive and Gender Dysphoria Care

At the Annual Meeting, the shareholders did not approve a shareholder proposal requesting a report on median compensation and benefits gaps as they address reproductive and gender dysphoria care. The following is a breakdown of the voting results:

For

Against

Abstain

Broker Non-Votes

5,153,879

864,501,617

7,214,547

127,972,619

Proposal 8 - Shareholder Proposal Requesting a Report on the Company’s Use of Diagnostic Tools Created by Politicized Corporate Partners

At the Annual Meeting, the shareholders did not approve a shareholder proposal requesting a report on the Company’s use of diagnostic tools created by politicized corporate partners. The following is a breakdown of the voting results:

For

Against

Abstain

Broker Non-Votes

6,335,450

863,459,994

7,074,599

127,972,619

Proposal 9 - Shareholder Proposal Requesting a Report on the Risks of the Company Excluding Religious Charities from its Employee-Gift Match Program

At the Annual Meeting, the shareholders did not approve a shareholder proposal requesting a report on the risks of the Company excluding religious charities from its employee-gift match program. The following is a breakdown of the voting results:

For

Against

Abstain

Broker Non-Votes

5,749,240

864,268,337

6,852,466

127,972,619

The above proposals are further described in the Company’s definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on January 26, 2026.